Anonymous ID: 013dde July 18, 2023, 7:56 a.m. No.19200615   🗄️.is 🔗kun   >>0657 >>0717 >>0768 >>0936 >>1039 >>1330 >>1398

Tropical Storm Don strengthensas it continues a slow spin through the north Atlantic

 

By Brian Shields, WFTV.com and James Tutten, WFTV.com

 

July 18, 2023 at 6:51 am EDT

 

ORLANDO, Fla. —Don strengtheneda little over the last 12 hours and is again classified as a tropical storm.

 

Tropical Storm Don is spinning in the north Atlantic, and it will continue to for several days.

 

The system will continue to drift around for about a week, but it has no threat to land.

 

Read: Hurricane season: Are you ready? Survey says many Floridians are not

 

Don remains only an issue for shipping routes.

 

It poses no threat to the United States.

 

https://www.wftv.com/news/local/tropical-storm-don-strengthens-it-continues-slow-spin-through-north-atlantic/DYEKTHY6A5AE5LUWUJZ7HZFKS4/

Anonymous ID: 013dde July 18, 2023, 8:16 a.m. No.19200699   🗄️.is 🔗kun

>>19200657

I think that's what the "poses no threat to the United States" means. <tongue in cheek>

 

We, the people are safe, but that foreign occupied land around our capital, not so much.

Anonymous ID: 013dde July 18, 2023, 8:34 a.m. No.19200808   🗄️.is 🔗kun   >>0815 >>0840 >>1039 >>1330 >>1398

Oh look, another new VAX for kids!

 

https://health.wusf.usf.edu/health-news-florida/2023-07-18/new-drug-to-protect-babies-and-toddlers-from-rsv-gets-fda-approval-ahead-of-cold-season

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

 

U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.

 

RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.

 

The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.

 

“Today’s approval addresses the great need for products to help reduce the impact of RSV disease on children, families and the health care system” said FDA's Dr. John Farley in a statement.